Simvastatin Induces Heme Oxygenase-1
- 7 September 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 110 (10) , 1296-1302
- https://doi.org/10.1161/01.cir.0000140694.67251.9c
Abstract
Background— Evidence from experimental and clinical studies indicates that statins can protect the vessel wall through cholesterol-independent mechanisms. The “pleiotropic” effects include the prevention of inflammation and proliferation of vascular cells. Here, we studied whether heme oxygenase-1 (HO-1), an important cytoprotective molecule, is induced by simvastatin and the role of HO-1 in the pleiotropic effects of simvastatin.Keywords
This publication has 21 references indexed in Scilit:
- Small Interfering RNA Targeting Heme Oxygenase-1 Enhances Ischemia-Reperfusion-induced Lung ApoptosisJournal of Biological Chemistry, 2004
- Relation of Inflammation and Benefit of Statins After Percutaneous Coronary InterventionsCirculation, 2003
- Simvastatin Lowers C-Reactive Protein Within 14 DaysCirculation, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Heme Oxygenase-1-derived Carbon Monoxide Requires the Activation of Transcription Factor NF-κB to Protect Endothelial Cells from Tumor Necrosis Factor-α-mediated ApoptosisJournal of Biological Chemistry, 2002
- Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in miceNature Medicine, 2002
- Pleiotropic effects of statins: do they matter?Current Opinion in Lipidology, 2001
- Mechanism of Heme Oxygenase-1 Gene Activation by Cadmium in MCF-7 Mammary Epithelial CellsJournal of Biological Chemistry, 2000
- Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages.Journal of Clinical Investigation, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996